← Back to Search

Dietary Supplement

Dietary supplements for Chronic Inflammation

N/A
Waitlist Available
Led By David Furman, PhD
Research Sponsored by Edifice Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, day 50, day 120 and day 210

Summary

This trial tests dietary supplements tailored to different immune system types in adults. The goal is to reduce chronic inflammation, which naturally increases with age, to slow down aging and improve health. Participants will be monitored through blood tests and wearable devices.

Eligible Conditions
  • Chronic Inflammation
  • Inflammaging

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, day 50, day 120 and day 210
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, day 50, day 120 and day 210 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in inflammatory age (iAge®) scores from Baseline to end of study intervention
Secondary study objectives
Anthropometric and metabolic measurements from Baseline to end of study intervention
Change in cardiovascular health from Baseline to end of study intervention
Change in frailty and mobility from Baseline to end of study intervention
+4 more
Other study objectives
Assessment of skin and scalp health from Baseline to end of study intervention
Changes in metabolomic profile
Changes in the gut microbiome at Baseline to end of study intervention in a subset of participants
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Dietary supplementsActive Control1 Intervention
Dietary supplements are either (1) designated as Generally Recognized As Safe (GRAS) by the Food and Drug Administration or (2) compounds at similar concentrations to those found in foods.
Group II: PlaceboPlacebo Group1 Intervention
Placebo-matched formulations

Find a Location

Who is running the clinical trial?

Edifice HealthLead Sponsor
David Furman, PhDPrincipal InvestigatorChairman of the Scientific Advisory Board
~184 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top